With a growing range of new vaccines coming on to the market and evidence that some countries simply could not sustain the significant increases in funding required to maintain immunisation programmes, Gavi's first-ever strategy incorporated a detailed review of how best to deploy its growing resources:

STRATEGIC GOALS

Four strategic goals underpinned Phase II

Strategic Goal 1

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner

Strategic Goal 2

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security

Strategic Goal 3

Increase the predictability and sustainability of long-term financing for national immunisation programmes

Increase the predictability and sustainability of long-term financing for national immunisation programmes

Strategic Goal 4 

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation

WORKPLAN, ACTIVITIES, OUTPUTS

With a total budget of US$ 297 million available for the strategy's four-year life cycle, any given year in the Gavi strategy contained up to 100 activities. To help measure progress, these activities are reported against 17 outputs.

The 2010 Work Plan Report highlights the 2010 progress under each output. It is based on the reporting provided by WHO, UNICEF, World Bank, AVI TAC and the Gavi Secretariat. The paper includes an annex table summarising the progress per output against the 2010 work plan targets.

Related downloads

Latest news

The Republic of Korea has announced a pledge of US$ 200 million to the Gavi COVAX Advance Commitment (Gavi COVAX AMC), with US$ 100 million to be provided in 2021 and an additional US$ 100 million to be provided in 2022

COVAX welcomes dose sharing commitments for 870 million additional doses to support equitable access to vaccines in 2021 and 2022, with the aim to deliver at least half by the end of 2021.

Geneva, 10 June 2021 – Gavi, the Vaccine Alliance, today welcomes the decision by the United States Government to procure 500 million COVID-19 vaccine doses on behalf of the COVAX Facility.

Last updated: 14 Jan 2020

Subscribe to our newsletter